Your browser doesn't support javascript.
loading
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay.
Lara, Primo N; Moon, James; Hesketh, Paul J; Redman, Mary W; Williamson, Stephen K; Akerley, Wallace L; Hirsch, Fred R; Mack, Philip C; Gandara, David R.
Afiliação
  • Lara PN; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: pnlara@ucdavis.edu.
  • Moon J; SWOG Statistical Center, Seattle, WA, USA.
  • Hesketh PJ; Lahey Hospital and Medical Center, Burlington, MA, USA.
  • Redman MW; SWOG Statistical Center, Seattle, WA, USA.
  • Williamson SK; University of Kansas Cancer Center, Kansas City, KS, USA.
  • Akerley WL; University of Utah Medical Center, Salt Lake City, UT, USA.
  • Hirsch FR; University of Colorado, Denver, CO, USA.
  • Mack PC; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.
  • Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.
J Thorac Oncol ; 11(3): 420-5, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26725184
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Cloridrato de Erlotinib / Neoplasias Pulmonares Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Cloridrato de Erlotinib / Neoplasias Pulmonares Idioma: En Ano de publicação: 2016 Tipo de documento: Article